Literature DB >> 32144497

Affected neural networks as basis of disturbed motor function in schizophrenia.

Andrea Schmitt1, Daniela Reich-Erkelenz2, Peter Falkai3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32144497      PMCID: PMC7069892          DOI: 10.1007/s00406-020-01116-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


× No keyword cloud information.
Based on the systematic assessment of symptoms, Emil Kraepelin over 100 years ago defined catatonia and motor symptoms as a feature of schizophrenia [1]. In fact, about two-third of first-episode schizophrenia patients exhibit motor deficits; in multi-episode patients, the frequency is even higher. Irrespective of motor side-effects of antipsychotic treatment, motor slowing has been detected during the early course of psychosis. In this issue, in antipsychotic-naive individuals at high risk for psychosis (CHR), Damme et al. [2] used a computerized finger tapping task and clinical interviews. They could demonstrate motor slowing in the CHR individuals compared to healthy controls and a relationship to negative, but not positive symptoms. Accordingly, in medicated young schizophrenia patients without extrapyramidal symptoms, better fine motor function was correlated with less-severe negative symptoms [3]. Neurological soft signs (NSS) refer to minor deficits in motor coordination, sensory integration, and disinhibition, and are highly prevalent in patients with schizophrenia, but also in those with bipolar or obsessive–compulsive disorder. In a large sample of patients with psychosis, motor dysfunction at baseline has also been related to symptoms of obsessive–compulsive after a follow-up of 3 years [4], suggesting that motor symptoms may precede co-occurring obsessive–compulsive symptoms. Individuals with ultra-high risk for psychosis have been shown to exhibit a higher prevalence of NSS sensory integration items than individuals with schizotypy and healthy controls, and these items could discriminate individuals at high risk from healthy controls with an accuracy of about 85% [5]. Therefore, NSS have been proposed as biomarkers to detect and to discriminate individuals in different stages of psychosis from healthy controls. In a large sample of patients with schizophrenia, their unaffected first-degree relatives, individuals with schizotypal personality disorder, other psychiatric patients and healthy controls, and patients along the schizophrenia continuum showed increased levels of NSS compared to healthy controls and other psychiatric patients. The abnormal developmental trajectory of NSS in schizophrenia supports the endophenotype hypothesis and relates NSS to neurodevelopmental disturbances [6]. In remitted schizophrenia patients, Feng et al. [7] investigated NSS and their association with cognitive deficits. They found that six subitems of NSS and neurocognitive deficits met criteria of endophenotype and hypothesized that covariation of sensory integration and cognitive domains including information processing speed, attention, and social cognition suggest an overlap of compromised underlying neural systems. NSS have been reported to be associated with disturbed cortical–subcortical–cerebellar circuitry in schizophrenia. Using a graph theoretical approach and regional network analysis, it has been demonstrated that NSS were associated with betweenness centrality involving the inferior orbital frontal cortex, the middle temporal cortex, the hippocampus, the supramarginal cortex, the amygdala, and the cerebellum. Global network analysis revealed NSS to be associated with the distribution of network hubs involving the superior medial frontal cortex, the temporal cortices, the postcentral cortex, the amygdala, and the cerebellum [8]. In individuals with ultra-high-risk for psychosis, NSS scores were associated with decreased gray matter volume in the superior and medial frontal cortex, the rectal cortex, the pre- and postcentral cortex, the insula, the caudate, and the cerebellum [9]. The cerebellum is well known to be involved in motor control, but functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) studies have also shown the involvement of the cerebellum in cognition. The cerebellum has been implicated in the pathophysiology of schizophrenia with the cortico-thalamo-cerebellar circuit receiving particular attention. However, the underlying mechanisms are unknown and are hypothesized to involve a glutamatergic deficit in cerebellar subregions of schizophrenia patients [10]. In future studies, multimodal neuroimaging should be applied to assess affected brain circuits and the pathophysiological basis of NSS during lifespan in individuals with psychosis.
  9 in total

1.  Neurological soft signs and grey matter abnormalities in individuals with ultra-high risk for psychosis.

Authors:  Li Kong; Huiru Cui; Tianhong Zhang; Ya Wang; Jia Huang; Yikang Zhu; Yingying Tang; Christina J Herold; Johannes Schröder; Eric F C Cheung; Raymond C K Chan; Jijun Wang
Journal:  Psych J       Date:  2018-12-04

2.  Neurological Soft Signs and Brain Network Abnormalities in Schizophrenia.

Authors:  Li Kong; Christina J Herold; Eric F C Cheung; Raymond C K Chan; Johannes Schröder
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

3.  Relationship between motor function and psychotic symptomatology in young-adult patients with schizophrenia.

Authors:  Shu-Mei Wang; Wen-Chen Ouyang; Ming-Yi Wu; Li-Chieh Kuo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-04-11       Impact factor: 5.270

4.  Neurological soft signs and neurocognitive deficits in remitted patients with schizophrenia, their first-degree unaffected relatives, and healthy controls.

Authors:  Yingying Feng; Zongqin Wang; Guorong Lin; Hong Qian; Zuohui Gao; Xiaoli Wang; Mingcao Li; Xiaohua Hu; Yi Li
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-05-23       Impact factor: 5.270

5.  Clinical Utility and Lifespan Profiling of Neurological Soft Signs in Schizophrenia Spectrum Disorders.

Authors:  Raymond C K Chan; Weizhen Xie; Fu-lei Geng; Ya Wang; Simon S Y Lui; Chuan-yue Wang; Xin Yu; Eric F C Cheung; Robert Rosenthal
Journal:  Schizophr Bull       Date:  2015-12-28       Impact factor: 9.306

6.  Detecting motor slowing in clinical high risk for psychosis in a computerized finger tapping model.

Authors:  Katherine S F Damme; K Juston Osborne; James M Gold; Vijay A Mittal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-20       Impact factor: 5.270

7.  Neurological soft signs precede the onset of schizophrenia: a study of individuals with schizotypy, ultra-high-risk individuals, and first-onset schizophrenia.

Authors:  Raymond C K Chan; Hui-Ru Cui; Min-Yi Chu; Tian-Hong Zhang; Ya Wang; Yi Wang; Zhi Li; Simon S Y Lui; Ji-Jun Wang; Eric F C Cheung
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-31       Impact factor: 5.270

8.  Longitudinal association between motor and obsessive compulsive symptoms in patients with psychosis and their unaffected siblings.

Authors:  Marije Swets; Frederike Schirmbeck; Jack Dekker; Lieuwe de Haan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-05-29       Impact factor: 5.270

9.  Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.

Authors:  Andrea Schmitt; Jiri Koschel; Mathias Zink; Manfred Bauer; Clemens Sommer; Josef Frank; Jens Treutlein; Thomas Schulze; Thomas Schneider-Axmann; Eleni Parlapani; Marcella Rietschel; Peter Falkai; Fritz A Henn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-05-12       Impact factor: 5.270

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.